Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with hypertrophic cardiomyopathy (a condition where the heart muscle becomes abnormally thick) through an ultrasound of the heart, whether or not there is a blockage affecting blood flow out of the heart
- People who are alert, mentally capable, and able to understand and willingly sign a consent form
- People who are able to participate in specific heart stress tests, non-invasive heart monitoring, and follow-up appointments during the study
Who may not be able to join:
- People who are 18 years of age or younger, or who are pregnant or breastfeeding
- People who have other heart or major blood vessel conditions that cause a blockage affecting blood flow out of the heart, such as severe narrowing of the aortic valve or certain structural abnormalities present from birth
- People who have ongoing irregular heart rhythms, such as persistent atrial fibrillation or other serious rhythm problems, that could affect the accuracy of heart monitoring during the study
- People who have previously had a procedure or surgery to treat a blockage in the heart's outflow pathway, such as alcohol septal ablation or surgical removal of heart muscle tissue
- People who have other health conditions that the trial doctors consider unsuitable for participation, including certain medical reasons that would make the heart stress tests unsafe (confirm with trial site)
- People who are currently taking part in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18833221133
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of SBP waveform in differentiating obstructive HCM caused by left ventricular outflow tract obstruction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.